RxVigilance Mobile 17+

Vigilance Sante Inc.

Designed for iPad

    • Free
    • Offers In-App Purchases

Screenshots

Description

RxVigilance - a reference tool for health care professionals that features information on drugs and health - can now be accessed from anywhere.

After installation, THE APPLICATION RESIDES ENTIRELY ON THE DEVICE and does not require an Internet connection for regular use. Internet access is required for updates.

Already used by thousands of physicians, pharmacists, nurses and other health care professionals across Canada, RxVigilance provides you with relevant and up to date information from several dozen leading reference sources. Drug monographs, pharmacological profile analysis, and information on natural products and travel destinations are among some of the many features you can now access through your device.

Our team of health care professionals is well aware of your day to day information needs. As a result, they are equipped to select what is most useful and relevant for you and your practice and to integrate that information to RxVigilance. In short, you will be able to access what you need quickly and effectively.

The RxVigilance Mobile App includes access to:

COMPARATIVE CHARTS
In the application users will find a series of charts comparing the characteristics of products from the same pharmacological class in order to help them make the best therapeutic decision based on onset of action or the number of administrations a day, for example.

MONOGRAPHS
Professional information on more than 1200 drugs. You can find information on adverse reactions, official and unofficial indications, adult dosages, pediatric dosages, geriatric dosages, adjustments for renal and hepatic impairment, precautions in pregnancy/breastfeeding, special precautions (grapefruit, stability, food, etc.), contraindications, interactions and kinetics. Monographs are regularly updated with information deemed relevant by our team of professionals.

TRAVEL
This feature allows to search for over 200 destinations. It provides access to brief and relevant overview of the destination (currency, languages, population, capital), required and/or recommended immunizations by country, recommendations based on diseases found in each country and contact details for service centres that may be of use while traveling.

NATURAL PRODUCTS
Information on more than 60 of the most commonly used natural products. It includes product indications (classified by evidence of effectiveness), product description and discussion on product safety and efficacy.

PROFILE ANALYSIS
Profile analysis allows to identify interactions and provides a description of the interactions as well as recommendations. Interactions are classified by importance of actions to be taken by the professional.

BULLETINS
Monthly communiqué for subscribers with details on the most recent updates and new developments and a list of monographs to which changes have been made. It is possible to refer to bulletins from prior months and send questions or comments via e-mail to the Rx Vigilance team.

PHONE DIRECTORY
A phone directory that consists of over 6000 useful contacts such as: hospitals, CLSCs, support groups and self-help groups, pharmacies, pharmaceutical companies, etc. It allows users to dial phone numbers directly from their iPhone and to acces links to internet sites when available.

What’s New

Version 2.0.113

October 2024
(monthly update)

Modifications to RxVigilance
=========================
Contraception and specific conditions

Following the 2024 update of the CDC's medical eligibility criteria for contraceptive use (U.S. MEC), we have refreshed our comparative chart on contraceptive methods in patients with certain common medical conditions (e.g., smoking, history of deep vein thrombosis or pulmonary embolism).

CNS depressant effect

In order to keep our alerts as relevant as possible, we have replaced our "Sedation" alerts with "CNS depressant effects" alerts. This change was made with the goal of identifying the additive risks of adverse effects such as drowsiness, reduced attention, and respiratory problems, which is particularly important in the context of the opiate crisis.
This alert will appear when analyzing the profile of patients most at risk, to help you manage their care.

QT interval

The list of medications that can prolong the QT interval has been updated.
Rivastigmine has been added to the list entitled Possible risk of torsades de pointes. In addition, osimertinib is now classified in the list Known risk of torsades de pointes.


New monographs
=========================
Ivosidenib (Tibsovo)
Landiolol (Sibboran)

App Privacy

The developer, Vigilance Sante Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Not Collected

The developer does not collect any data from this app.

Privacy practices may vary based on, for example, the features you use or your age. Learn More

You Might Also Like

Lanthier
Medical
INESSS
Medical
The Perinatal Memo
Medical
Mini-Guide Palli-Science
Medical
Antibiothérapie Pédiatrique
Medical
EZResus
Medical